Trial · NCT01284959
Results by group99
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 99
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Risperidone | NIDSS-Avolition | -1.30 | Standard Deviation 1.22 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Placebo | NIDSS-Avolition | -0.28 | Standard Deviation 0.64 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Paliperidone ER | NIDSS-Avolition | -0.66 | Standard Deviation 0.53 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Risperidone | NIDSS-Blunted Affect | -0.70 | Standard Deviation 0.74 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Placebo | NIDSS-Blunted Affect | 0.02 | Standard Deviation 0.35 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Paliperidone ER | NIDSS-Blunted Affect | -0.24 | Standard Deviation 0.64 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Risperidone | NIDSS-Cognition | -0.54 | Standard Deviation 0.53 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Placebo | NIDSS-Cognition | 0.02 | Standard Deviation 0.26 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Paliperidone ER | NIDSS-Cognition | -0.38 | Standard Deviation 0.39 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Risperidone | NIDSS-Total | -0.77 | Standard Deviation 0.70 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Placebo | NIDSS-Total | -0.06 | Standard Deviation 0.35 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Paliperidone ER | NIDSS-Total | -0.42 | Standard Deviation 0.38 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Risperidone | SANS-Global score for alogia | 0.67 | Standard Deviation 0.50 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Placebo | SANS-Global score for alogia | 0 | Standard Deviation 0 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Paliperidone ER | SANS-Global score for alogia | 0 | Standard Deviation 0 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Risperidone | SANS-Global score for blunted affect | 0.67 | Standard Deviation 0.50 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Placebo | SANS-Global score for blunted affect | 0 | Standard Deviation 0 | units on a scale |
| Assessment of Negative Symptoms and Neuroleptic Induced Deficit Syndromes by Objective Rating Scales | Paliperidone ER | SANS-Global score for blunted affect | 0.10 | Standard Deviation 0.32 | units on a scale |
| Assessment of Adverse Events by Objective Rating Scales and Self Report Scales | Risperidone | VAS-Total score | 5.41 | Standard Deviation 1.82 | units on a scale |
| Assessment of Adverse Events by Objective Rating Scales and Self Report Scales | Placebo | VAS-Total score | 3.35 | Standard Deviation 1.69 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01284959/results